Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation Using Intragen Fractional Radiofrequency With NeuViVa for the Treatment of Vaginal Laxity and Urogynecology Symptoms.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03280446
Recruitment Status : Unknown
Verified March 2018 by SHERRY Thomas, The American Association of Female Pelvic Medicine Specialists, Inc..
Recruitment status was:  Recruiting
First Posted : September 12, 2017
Last Update Posted : March 23, 2018
Sponsor:
Information provided by (Responsible Party):
SHERRY Thomas, The American Association of Female Pelvic Medicine Specialists, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : August 2018
Estimated Study Completion Date : August 2019